95 related articles for article (PubMed ID: 15244525)
1. Comparative evaluation of antiproliferative activity and induction of apoptosis by some fluoroquinolones with a human non-small cell lung cancer cell line in culture.
Mondal ER; Das SK; Mukherjee P
Asian Pac J Cancer Prev; 2004; 5(2):196-204. PubMed ID: 15244525
[TBL] [Abstract][Full Text] [Related]
2. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Nozaki-Renard J; Iino T; Sato Y; Marumoto Y; Ohta G; Furusawa M
Cell Struct Funct; 1990 Oct; 15(5):295-9. PubMed ID: 2085844
[TBL] [Abstract][Full Text] [Related]
4. Does ciprofloxacin have an obverse and a reverse?
Kloskowski T; Gurtowska N; Drewa T
Pulm Pharmacol Ther; 2010 Oct; 23(5):373-5. PubMed ID: 20211752
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
[TBL] [Abstract][Full Text] [Related]
6. Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Romero IC; Saravia NG; Walker J
J Parasitol; 2005 Dec; 91(6):1474-9. PubMed ID: 16539034
[TBL] [Abstract][Full Text] [Related]
7. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
8. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
[TBL] [Abstract][Full Text] [Related]
9. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Griffiths NM; Hirst BH; Simmons NL
J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Ono C; Tanaka M
J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro.
Holtom PD; Pavkovic SA; Bravos PD; Patzakis MJ; Shepherd LE; Frenkel B
J Orthop Res; 2000 Sep; 18(5):721-7. PubMed ID: 11117292
[TBL] [Abstract][Full Text] [Related]
12. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Vanajothi R; Srinivasan P
J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
14. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
15. [Effect of drugs of the fluoroquinolone series on morphokinetic parameters of the cellular elements of lung tissue].
Kunichan AD; Mozhokina GN; Shapatava MN
Antibiot Khimioter; 1996 Apr; 41(4):51-3. PubMed ID: 8967811
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation.
Yadav V; Varshney P; Sultana S; Yadav J; Saini N
BMC Cancer; 2015 Aug; 15():581. PubMed ID: 26260159
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
[TBL] [Abstract][Full Text] [Related]
19. Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivatives.
Vargas F; Zoltan T; Ramirez AH; Cordero T; Chavez V; Izzo C; López V; Cárdenas YM; Fernández A; Hincapie L; Fuentes A
Pharmazie; 2009 Feb; 64(2):116-22. PubMed ID: 19320285
[TBL] [Abstract][Full Text] [Related]
20. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
